Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | |
|---|---|---|---|---|---|
| Sales | 599.55 | 433.42 | 424.16 | 294.66 | 215.84 |
| Operating profit | 113.71 | 71.49 | 63.33 | 36.45 | 24.18 |
| Interest | 5.35 | 7.29 | 6.56 | 7.67 | 3.44 |
| Gross profit | 139.52 | 64.37 | 64.70 | 28.90 | 27.58 |
| EPS (Rs) | 2.40 | 0.93 | 1.07 | 0.30 | 0.30 |
Annual
results in details
| Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | |
|---|---|---|---|---|---|
| Other income | 31.16 | 0.17 | 7.93 | 0.12 | 6.83 |
| Stock adjustment | 0.55 | -5.63 | -2.71 | -3.72 | 0.67 |
| Raw material | 291.29 | 209.20 | 208.14 | 154.74 | 100.88 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 54.64 | 48.51 | 46.33 | 45.86 | 40.17 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 139.35 | 109.85 | 109.07 | 61.34 | 49.93 |
| Provisions made | - | - | - | - | - |
| Depreciation | 15.19 | 11.64 | 8.69 | 12.25 | 15.00 |
| Taxation | 25.95 | 14.82 | 12.39 | 4.23 | 0.35 |
| Net profit / loss | 98.38 | 37.90 | 43.62 | 12.43 | 12.23 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 18.97 | 16.49 | 14.93 | 12.37 | 11.20 |
| GPM (%) | 22.12 | 14.85 | 14.97 | 9.80 | 12.39 |
| NPM (%) | 15.60 | 8.74 | 10.09 | 4.22 | 5.49 |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis